Ramcharan Priya, Katwaroo Arun R, Hosein Reyaz, Maharaj Nicole, Swarath Steven M, Seecheran Valmiki, Seecheran Rajeev V, Seecheran Naveen A
Cardiology, North Central Regional Health Authority, Mt. Hope, TTO.
Internal Medicine, Trinidad Institute of Medical Technology, St. Augustine, TTO.
Cureus. 2024 Jun 10;16(6):e62052. doi: 10.7759/cureus.62052. eCollection 2024 Jun.
Recent studies suggest a potential association between myocardial bridging (MB) and accelerated atherosclerotic plaque formation. We describe the case report of a 37-year-old South Asian male with no established risk factors for coronary artery disease (CAD) who presented with a non-ST-segment-elevation acute coronary syndrome (NSTE-ACS) with a coincident widowmaker lesion and severe MB. He was successfully managed with comprehensive guideline-directed medical therapy (GDMT) and urgent percutaneous coronary intervention (PCI) of the culprit lesion, sparing the MB segment. The clinician should be cognizant of MB implicating ACS as a major adverse cardiovascular event (MACE) and its key management strategies.
近期研究表明，心肌桥（MB）与动脉粥样硬化斑块形成加速之间可能存在关联。我们报告一例37岁南亚男性病例，该患者无冠心病（CAD）既定危险因素，却出现非ST段抬高型急性冠状动脉综合征（NSTE-ACS），同时伴有“寡妇制造者”病变及严重心肌桥。通过全面的指南导向药物治疗（GDMT）及对罪犯病变进行紧急经皮冠状动脉介入治疗（PCI），成功对其进行了治疗，未处理心肌桥段。临床医生应认识到心肌桥可引发急性冠状动脉综合征作为主要不良心血管事件（MACE）及其关键管理策略。
